Thomas Nevers

Papers

Total Citations

H-Index

About

Thomas Nevers is a prominent urologic oncologist whose research centers on improving surgical outcomes for prostate cancer patients, with a particular focus on robotic-assisted laparoscopic radical prostatectomy (RALP). His most-cited work, a 2012 study examining biochemical recurrence rates after RALP, provides critical insights into how surgical margin status influences long-term cancer control. By analyzing data from a large institutional database, Nevers demonstrated that positive surgical margins significantly elevate the risk of biochemical recurrence, offering surgeons evidence-based benchmarks for operative success and postoperative monitoring. This contribution has informed clinical decision-making for thousands of patients, with the study accumulating 28 citations as a cornerstone reference in the field. Beyond this seminal paper, Nevers has advanced the understanding of minimally invasive prostate cancer surgery, contributing to the refinement of techniques that reduce recovery times while maintaining oncologic efficacy. His work bridges the gap between surgical innovation and patient outcomes, making him a respected voice in urologic oncology. For students and researchers, Nevers exemplifies how rigorous database analysis can translate into tangible improvements in cancer care.